Health In Tech Appoints Former SAP and IBM Executive Sri Rajagopalan as Chief Technology Officer to Advance AI-driven Enterprise-Grade Platform Growth
Rhea-AI Summary
Health In Tech (Nasdaq: HIT) appointed Sri Rajagopalan as Chief Technology Officer, effective Feb 23, 2026. He served as Interim CTO since November 2025 and will lead product engineering, cloud-native platform scaling, AI roadmap, data governance, and cybersecurity.
The role emphasizes modernizing enterprise-grade platform architecture to support underwriting, claims, benefits administration, and expansion to larger carrier and broker partners.
Positive
- CTO appointment effective Feb 23, 2026
- Interim CTO since November 2025 with documented platform modernization efforts
- Mandate to scale AI-enabled, cloud-native enterprise platform
Negative
- No financial or timeline metrics provided for platform ROI or partner commitments
News Market Reaction – HIT
On the day this news was published, HIT gained 1.67%, reflecting a mild positive market reaction. This price movement added approximately $1M to the company's valuation, bringing the market cap to $68M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
HIT slipped -0.84% with low volume while peers were mixed: DUOT -1.06%, EXFY -0.8% versus SSTI +2.26%, SVCO +1.49%, ASUR +1.01%, pointing to a stock-specific reaction.
Previous AI Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 12 | AI summit agenda | Positive | -2.4% | Unveiled full hitDavos 2026 InsurTech summit agenda focused on AI themes. |
| Sep 05 | AI leadership changes | Positive | -2.9% | Announced AI-focused leadership roles to drive innovation and enterprise revenue growth. |
AI-tagged leadership and strategy updates have previously been followed by modest negative price reactions despite their growth-focused tone.
Recent history for Health In Tech shows a series of leadership and AI-focused strategy announcements. On Jan 12, 2026, the hitDavos 2026 AI-centric summit news saw a -2.42% move. Earlier, on Sep 5, 2025, AI leadership changes tied to launching a next‑generation AI Engine coincided with a -2.85% reaction. Today’s CTO appointment, also framed around advancing AI and enterprise-scale platforms, fits this pattern of strategically important, technology-driven updates.
Historical Comparison
Past AI-tagged releases, including leadership and summit updates, averaged a -2.63% move, suggesting investors have reacted cautiously to AI strategy news.
AI-tagged history shows a progression from defining AI leadership and strategy to showcasing AI thought leadership, now extending into CTO-level execution on the AI platform roadmap.
Market Pulse Summary
This announcement reinforces Health In Tech’s focus on scaling a secure, cloud-native, AI-enabled platform under an experienced CTO. It follows earlier AI leadership and summit news that framed the company’s innovation agenda. Investors may watch how this hire translates into platform modernization, underwriting and claims automation, and whether strong Q3 2025 results—revenue of $8.49M and net income of $452,176—are sustained as the technology roadmap advances.
Key Terms
ai-enabled technical
cloud-native technical
enterprise-grade technical
underwriting financial
benefits administration financial
forward-looking statements regulatory
AI-generated analysis. Not financial advice.
Mr. Rajagopalan has served as Health In Tech's Interim CTO since November 2025, during which time he has provided decisive technology leadership and advanced the company's AI-driven transformation strategy. As Interim CTO, he has strengthened architectural discipline, accelerated platform modernization, and delivered measurable execution across mission-critical technology initiatives.
As Chief Technology Officer, Mr. Rajagopalan oversees end-to-end product engineering and enterprise platform operations. He is responsible for advancing Health In Tech's next-generation technology architecture and AI development roadmap and embedding artificial intelligence, automation, and data intelligence across underwriting, claims, and benefits administration workflows. His mandate includes building, scaling, and optimizing the company's cloud-native, enterprise-grade platforms to enhance performance, security, interoperability, and scalability and position Health In Tech to execute on its long-term enterprise vision and forthcoming strategic growth initiatives.
Mr. Rajagopalan has more than two decades of enterprise-scale technology leadership, with global experience in software engineering, cloud transformation, data and AI platforms, and developing enterprise architecture frameworks that support large-scale operations.
Prior to joining Health In Tech, Mr. Rajagopalan spent the majority of his career at SAP and IBM, two of the world's leading enterprise software companies, where he held senior leadership roles in enterprise architecture and large-scale platform engineering. His experience spans global, mission-critical systems serving complex enterprise clients across multiple industries.
Since 2019, he has focused exclusively on the healthcare technology sector, serving as Senior Vice President of Software Engineering at Net Health, Senior Vice President of Platform Engineering at Zelis, and Vice President of Software Engineering & Chief Architect at Greenway Health. Across these roles, he led large engineering organizations, modernized core platforms, and scaled high-performance, transaction-intensive systems—bringing deep expertise in healthcare payments, claims technology, and data-driven platform transformation to Health In Tech.
"Sri's deep enterprise architecture and large-scale platform engineering experience comes at a pivotal moment in Health In Tech's evolution," said Tim Johnson, Chief Executive Officer of Health In Tech. "He has led global engineering organizations, modernized complex legacy systems, and delivered mission-critical infrastructure at true enterprise scale. As we expand our AI-enabled underwriting and benefits administration platform, Sri will strengthen our core technology foundation—enhancing scalability, data intelligence, cybersecurity, and operational resilience. We believe his leadership positions us to support larger carrier and broker partners, execute multiple strategic initiatives in parallel, and build the enterprise-grade infrastructure required for sustained long-term growth."
"Health In Tech is entering an exciting phase of technology acceleration," said Rajagopalan. "My priority is to scale a secure, cloud-native, AI-enabled platform architecture that supports high-volume transaction processing, advanced data analytics, and seamless ecosystem integrations. We will continue modernizing our engineering practices, strengthening data governance and security frameworks, and building a resilient, enterprise-class infrastructure capable of supporting rapid distribution expansion and product innovation. I look forward to leading our technology organization as we advance the next generation of Health In Tech's intelligent platform ecosystem."
Use of Forward‑Looking Statements
Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the
About Health In Tech
Health In Tech, Inc. (Nasdaq: "HIT") is an AI-enabled InsurTech platform company, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and third party administrators. Learn more at healthintech.com.
Investor Contact
Investor Relations:
ir@healthintech.com
SOURCE Health In Tech Inc.